| AI in Life Sciences Market to Worth USD 69.34 Billion by 2031, at a CAGR of 26.3% – MarketsandMarkets™ |
Globe Newswire |
11/04 |
09:30 |
| Translational Data from Anal Cancer Patients Show Pelareorep Drives HPV-Specific Immune Responses, Supporting its Potential Across HPV-Driven Cancers |
Globe Newswire |
11/04 |
09:30 |
| KingSong Introduces F16 AVEN With Modular Design and Quick Release Motor Access |
Globe Newswire |
11/04 |
09:29 |
| Applied Biologics Announces Full Enrollment of BIOxHEAL™ Phase 3 Sentinel Safety Cohort |
Globe Newswire |
11/04 |
09:21 |
| MEGL Secures US$100 Million Dedicated Credit Facility to Accelerate Cross-Border Timber Trading |
Globe Newswire |
11/04 |
09:20 |
| Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2026 |
Globe Newswire |
11/04 |
09:15 |
| Cullinan Therapeutics Announces Presentations for CLN-049, a FLT3 T Cell Engager, and Velinotamig, a BCMA T Cell Engager, at the 68th ASH Annual Meeting |
Globe Newswire |
11/04 |
09:14 |
| Sensolus Supply Chain Velocity Index: 1 in 3 Industrial Assets Sat Still for an Entire Month |
Globe Newswire |
11/04 |
09:08 |
| Aggreko Introduces New Line of Battery Energy Storage Systems for Immediate and Large-Scale Applications |
Globe Newswire |
11/04 |
09:07 |
| Harsco Rail Executes Agreement to Exit Deutsche Bahn Engineered-to-Order Contract and Receives Initial Payment from Sale of Project Assets to GBM |
Globe Newswire |
11/04 |
09:05 |
| Tangram Announces Oral Presentation of TGM-148 Preclinical Data Highlighting Context-Dependent Mechanism of Action at the American Society of Hematology (ASH) 2026 Annual Meeting |
Globe Newswire |
11/04 |
09:05 |
| Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the 68th ASH Annual Meeting and Exposition |
Globe Newswire |
11/04 |
09:05 |
| SoundHound AI and Ultraviolette Announce Major Expansion of Agentic Voice AI Across Global Electric Vehicle Lineup |
Globe Newswire |
11/04 |
09:05 |
| Circana Launches Concept Testing and Forecasting Solutions to Help Brands Identify Winning Product Ideas and Predict Sales Potential |
Globe Newswire |
11/04 |
09:05 |
| Doba Adds $20 Cash Bonus to Referral Program for Ecommerce Marketers |
Globe Newswire |
11/04 |
09:05 |
| Disc Medicine Announces Multiple Presentations Across Portfolio at the 68th American Society of Hematology (ASH) Annual Meeting |
Globe Newswire |
11/04 |
09:05 |
| Formica Corporation Expands Design Possibilities with New Everform® Solid Surface and Homapal® Decors |
Globe Newswire |
11/04 |
09:03 |
| Solu Therapeutics to Present Initial Phase 1 Results of STX-0712 and New Preclinical Data on STX-0640 in Two Oral Presentations at the 2026 ASH Annual Meeting |
Globe Newswire |
11/04 |
09:02 |
| Lyell Immunopharma Announces $80 Million Private Placement to Advance Ronde-Cel Toward Planned BLA Submission |
Globe Newswire |
11/04 |
09:02 |
| Kura Oncology and Kyowa Kirin to Present First Ziftomenib-FLT3 Inhibitor Clinical Data at ASH 2026 |
Globe Newswire |
11/04 |
09:02 |
| Lakefront Biotherapeutics Announces Poster Presentation at the 2026 American Society of Hematology Meeting |
Globe Newswire |
11/04 |
09:01 |
| Corvus Pharmaceuticals Announces Initial Data from Soquelitinib Clinical Trial in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) will be Presented at the 68ᵗʰ American Society for Hematology Annual Meeting & Exposition |
Globe Newswire |
11/04 |
09:01 |
| Syndax to Host ASH Investor Event in Person and via Webcast on December 14, 2026 |
Globe Newswire |
11/04 |
09:01 |
| Agios to Highlight Strength and Differentiation of Rare Hematology Portfolio with New Clinical Data for Mitapivat in Sickle Cell Disease and AG-236 in Polycythemia Vera at ASH 2026 |
Globe Newswire |
11/04 |
09:01 |
| Lyell Immunopharma to Present Positive Updated Ronde-Cel Data in More than 80 Patients at ASH 2026 from PiNACLE Pivotal Trial in 3L+ and from Phase 1/2 2L Cohort in Patients with Relapsed/Refractory Large B-Cell Lymphoma |
Globe Newswire |
11/04 |
09:01 |
